13201144 エントリを集積


updatenews @ hr.sub.jp

newsplus summarization

Amazon レビュー summarization

価格.com summarization

アットコスメ summarization

食べログ summarization

楽天レビュー summarization

TSUTAYA レビュー 要約

じゃらん レビュー 要約

Splog Filter

最新 24時間         急減少ワード         cyclic        
  インターネット ( 651 )     ニュース ( 2876 )     アニメ ( 2209 )     コンビニ小売 ( 477 )     スポーツ ( 2818 )     映画 ( 1746 )     ゲーム ( 1649 )     芸能 エンタメ ( 1206 )     政治 国際 ( 2239 )     飲食 ( 1327 )     音楽 ( 3516 )     ドラマ ( 1679 )     ハードウェア ( 496 )     ソフトウェア ( 212 )     医療 健康 ( 707 )     時季 ( 1104 )     テクノロジー ( 460 )     自動車 ( 428 )     ビジネス 経済 ( 1300 )     ファッション ( 460 )     書籍 ( 938 )     漫画 ( 1267 )     番組 ( 737 )     料理 ( 847 )     家電 ( 154 )     レジャー ( 1161 )     学術 科学 ( 469 )     地域 ( 1443 )     フレーズ ( 277 )     コスメティック ( 212 )     自然 ( 1160 )     ファンシー ( 157 )     お笑い ( 463 )     趣味 ( 234 )     学校 ( 402 )     ギャンブル ( 1081 )     アート 芸術 ( 188 )     生活 ( 266 )  


    医療 健康 関連語 ステロイド バファリン 血栓
    • Aspirin the little pill with a big impact on cancer
      It is not yet a panacea for all ills, but it is getting close. Yesterday, researchers announced the first proof that aspirin can cut the risk of a range of cancers by up to 50 per cent.It is already taken by millions to protect... それはまだすべての病気の万能薬ではないが、それは近くなってきている

    • Aspirin could cut cancer chances - study
      LONDON - A low dose of aspirin may reduce colon cancer cases by a quarter and deaths by a third, a new study found.But experts say aspirin's side effects of bleeding and stomach problems are too worrying for people who aren't... ロンドンは、 - 低用量のアスピリンは、第三、四半期や死亡によって大腸癌症例を減らすことが、新たな研究found.Butの専門家は、出血や胃の問題はアスピリンの副作用もされていない人々のため心配していると言う...

    • Groceries Fill Aisles at Stores Like CVS
      Retailers known for selling clothes or aspirin, like Walgreens, CVS and Target, are expanding into the grocery business, with fresh produce, frozen meats and even sushi. 販。洋服やアスピリン、ウォルグリーン、CVSやターゲットなどで知られる小売業者は、新鮮な農産物、冷凍肉もお寿司と、食料品事業に拡大しています

    • 僕も貴方も同じように笑うなら、僕は笑わない。
      bgmはbump of chickenのpontsuka

    • Revealed to little acclaim - the pill that prevents cancer
      If Big Pharma had unveiled a brand new drug that would stop 20% of cancer deaths, the hype would be enormous and the pressure to buy it, at an inevitably high cost, huge. But it exists - it's called aspirin, it costs almost nothing and the revelation of its potential failed to make most front pagesOn my way home from work last night, I stopped at the chemist and bought a small plastic tub containing what appears to be the world's first genuine miracle drug. Low-dose aspirin. The tub contained 100 small pills, each one 75g. It cost just over £1. If a team of researchers at Oxford University, publishing today in the Lancet medical journal are to be believed, taking one of these a day for at least five years and preferably much longer can cut your risk of cancer by 20% or more.You would have thought the bunting would be flying from the lamp posts and champagne popping in the street. The Big C is supposed to be everybody's biggest dread. We are constantly exhorted to stop smoking, eat more fruit and vegetables and cut our weight - all of which would help save us from cancer, but which so many of us seem to find so hard to do. And now we have a once-a-day pill that can substantially reduce the risk - in the case of gastrointestinal cancer by over 50%.And yet the coverage has been relatively subdued, the excitement level low. While the BBC's Today programme led its news bulletins with the story and Sky News did a package, the newspapers - with the exception of the Express which carries a weekly miracle pill story - failed to run it on the front pages. My story, under heavy competition with the latest from WikiLeaks, made page 8.Why is this?Familiarity breeds contempt, they say. We already know aspirin can help prevent heart attacks and stroke. People may feel they have heard 大手製薬会社は、がんによる死亡の20%を停止する新しい薬を発表した場合は、誇大広告は、巨大なれる圧力は、必然的に高コストで、巨大なそれを購入する

    • New trials launch of a daily polypill which could potentially save millions of lives
      A new trial of the Red Heart polypill, four drugs in a single tablet, launches today to assess whether those at risk of heart attacks and strokes will take it regularly and whether it will saves lives.As the world changes, so do patterns of disease. Heart attacks and strokes used to be thought of as the burden of rich countries. Increasingly, cardiovascular disease is spreading across the developing world.In rich countries, those at risk of a heart attack may be offered a whole load of different protective pills. But in developing countries, there is little in the way of preventive medicine, most pills are expensive and few patients take the sort of daily drug cocktails that keep some people well in the west.But the polypill could change all that. A major new trial launches tomorrow to find out whether the Red Heart Pill, as it has been christened, could be a simple solution. It is four preventative drugs in a single, daily, cheap tablet. It contains low dose aspirin, a statin and two blood pressure-lowering medicines. All of them are cheap generic drugs.Some think the polypill has such potential in preventing heart attacks and strokes that it ought to be widely available in Europe to those who have even low risk factors, such as overweight and high blood pressure. But there are issues around dosing healthy people with drugs - particularly aspirin.But people who are at high risk - those who have already had one heart attack or stroke, for instance - are a different matter. And in countries like India, there are many people in that situation who have no chance of medicines - they are unavailable or too expensive. The vast majority of people have to pay for treatment.The UMPIRE trial (Use of a Multidrug Pill In Reducing cardiovascular Events) launches today in London in t レッドハートpolypillの新しい試験では、1錠の4つの薬は、今日これらの心臓発作や脳卒中の危険にさらさかどうかを定期的にかどうかは意志がlives.As世界の変更を保存してかかる評価するために起動すると、その病気のパターンを行う


    楽譜 共有     研究開発